Latest news
The OncFive: Top Oncology Articles for the Week of 8/2 - OncLiveOncLive · Sat, 08 Aug 2026 10:13:24 GMTThe Mechanism of Action of Evorpacept in Breast Cancer - OncLiveOncLive · Fri, 07 Aug 2026 11:00:32 GMTOutlining Questions About the Future of HR+ Breast Cancer Care - OncLiveOncLive · Thu, 06 Aug 2026 21:50:00 GMTExplaining ctDNA Analysis Findings From SERENA-6 in Breast Cancer - OncLiveOncLive · Wed, 05 Aug 2026 02:10:38 GMTNCCN Guidelines Add Gedatolisib-Based Regimens for Pretreated PIK3CA Wild-Type Advanced Breast Cancer - OncLiveOncLive · Mon, 03 Aug 2026 15:13:18 GMTThe Rationale to Wait for Radiographic Progression Before Switching Breast Cancer Therapy - OncLiveOncLive · Mon, 03 Aug 2026 14:55:00 GMTNCCN Lists Gedatolisib Regimens as Preferred Option in HR+/HER2– Metastatic Breast Cancer - Targeted OncologyTargeted Oncology · Fri, 31 Jul 2026 15:09:03 GMTCELC|Celcuity Inc|Price:83.170|Chg%:+0.710 - TradingKeyTradingKey · Mon, 27 Jul 2026 05:54:15 GMT